ADC Therapeutics SA (ADCT) stock news · rev $40.1M
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
This ADCT news page leads with what ADC Therapeutics SA filed — not a scraped headline mill.
No cached 8-K sentence for ADCT yet. We will not pad this page with generic market recap.
Latest reported ADCT revenue for 2026-06-30 was $40.1M. Net income was -$49.5M. Revenue was up 92.3% from 2026-03-31 to 2026-06-30. ADCT currently screens at market cap $141.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ADCT stock page; for the tape open the quote page.
Not investment advice.